McKinsey paid $650M to settle federal criminal and civil probes over Purdue Pharma opioid consulting
Dec 13, 2024McKinsey agreed to pay $650 million to resolve federal criminal and civil investigations into its consulting work advising Purdue Pharma on strategies to turbocharge OxyContin sales between 2004-2019. The firm advised on targeting high-volume prescribers and communities already hard-hit by opioids, and recommended cash prizes to boost sales. This marked the first time a management consulting firm was held criminally responsible for advice resulting in client crime. McKinsey also paid $573M to 47 states in a separate 2021 settlement.